Cargando…

The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review

OBJECTIVE: In this review, we aim to summarize the most recent data on the surgical management of oligometastatic non-small cell lung cancer (NSCLC). BACKGROUND: Approximately 60–70% of all patients with NSCLC initially present with advanced stages of cancer at time of diagnosis. These patients are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berzenji, Lawek, Debaenst, Sophie, Hendriks, Jeroen M. H., Yogeswaran, Suresh Krishan, Lauwers, Patrick, Van Schil, Paul E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Oligometastatic NSCLC: Definition and Treatment Opportunities
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350094/ https://www.ncbi.nlm.nih.gov/pubmed/34430376 http://dx.doi.org/10.21037/tlcr-21-58

Ejemplares similares

Oligometastatic non-small cell lung cancer: from biology to clinical practice
por: Infante, Maurizio V., et al.
Publicado: (2021)

How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
por: Remon, Jordi, et al.
Publicado: (2021)

Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review
por: Cortinovis, Diego, et al.
Publicado: (2021)

Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review
por: Mentink, Jill F., et al.
Publicado: (2021)

Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
por: Sundahl, Nora, et al.
Publicado: (2021)

Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer
por: Rashdan, Sawsan, et al.
Publicado: (2021)

Current and future research efforts in oligometastatic non-small cell lung cancer—a systematic review
por: Brandão, Mariana, et al.
Publicado: (2021)

Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis
por: Gobbini, Elisa, et al.
Publicado: (2021)

Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
por: Bertolaccini, Luca, et al.
Publicado: (2021)

A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done
por: Belluomini, Lorenzo, et al.
Publicado: (2021)

Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review
por: Fallet, Vincent, et al.
Publicado: (2021)

Local ablative therapies in oligometastatic NSCLC-upfront or outback?—a narrative review
por: Tjong, Michael C., et al.
Publicado: (2021)

Local for advanced, is this a paradox?
por: Bungaro, Maristella, et al.
Publicado: (2021)

Alternative methods for local ablation—interventional pulmonology: a narrative review
por: Olive, Gerard, et al.
Publicado: (2021)

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
por: Van Schil, Paul E., et al.
Publicado: (2017)

Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
por: Berzenji, Lawek, et al.
Publicado: (2023)

Good’s syndrome and COVID-19: case report and literature review
por: Berzenji, Lawek, et al.
Publicado: (2022)

Multimodality Treatment including Surgery Related to the Type of N2 Involvement in Locally Advanced Non-Small Cell Lung Cancer
por: Allaeys, Toon, et al.
Publicado: (2022)

Safety and Feasibility of Lung Cancer Surgery under the COVID-19 Circumstance
por: Berzenji, Lawek, et al.
Publicado: (2022)

Pulmonary metastasectomy in colorectal carcinoma
por: Beckers, Paul, et al.
Publicado: (2021)

The Peninsula stage III non-small cell lung cancer audit: assessing the impact of COVID-19 on treatment decisions
por: Smith, Philippa, et al.
Publicado: (2023)

Multimodality treatment of malignant pleural mesothelioma
por: Berzenji, Lawek, et al.
Publicado: (2018)

Part-solid tumours: at the border of 2 worlds
por: Van Schil, Paul E, et al.
Publicado: (2021)

Surgery after Induction Targeted Therapy and Immunotherapy for Lung Cancer
por: Allaeys, Toon, et al.
Publicado: (2021)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
por: Cui, W., et al.
Publicado: (2021)

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center
por: Pierre, C., et al.
Publicado: (2021)

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
por: Marin, E., et al.
Publicado: (2021)

Conservative Treatment of a Floating Mural Thrombus in the Descending Aorta
por: Goedemé, Johannes, et al.
Publicado: (2021)

Update on Pulmonary Ossifications in the Differential Diagnosis of Solitary Pulmonary Nodules
por: Gielis, Jan F., et al.
Publicado: (2021)

Biomarkers for Chronic Lung Allograft Dysfunction: Ready for Prime Time?
por: Verleden, Stijn E., et al.
Publicado: (2022)

Diabetic Retinopathy: Battling the Global Epidemic
por: Das, Arup
Publicado: (2016)

Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop
por: Nair, Prashant, et al.
Publicado: (2016)

Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases
por: Csaky, Karl, et al.
Publicado: (2018)

Opportunities from the Center for Perioperative Education
Publicado: (2006)

Opportunities from the Center for Perioperative Education
Publicado: (2006)

Opportunities from the Center for Perioperative Education
Publicado: (2006)

Report From the National Eye Institute Workshop on Neuro-Ophthalmic Disease Clinical Trial Endpoints: Optic Neuropathies
por: Levin, Leonard A., et al.
Publicado: (2021)

Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop
por: Levine, S. Robert, et al.
Publicado: (2023)

Surgical treatment of early-stage non-small-cell lung cancer
por: Van Schil, Paul E., et al.
Publicado: (2013)

OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening
por: Deben, Christophe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vpbtq7bbaqbjnbuvj89nrktj3m